{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:56:46Z","timestamp":1793987806078,"version":"4.8.0"},"reference-count":40,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RFA-2203-39281"],"award-info":[{"award-number":["RFA-2203-39281"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Jane and Aatos Erkko Foundation","award":["#220026"],"award-info":[{"award-number":["#220026"]}]},{"name":"InFLAMES Flagship Programme of the Research council of Finland","award":["337530"],"award-info":[{"award-number":["337530"]}]},{"name":"InFLAMES Flagship Programme of the Research council of Finland","award":["357910"],"award-info":[{"award-number":["357910"]}]},{"name":"InFLAMES Flagship Programme of the Research council of Finland","award":["358823"],"award-info":[{"award-number":["358823"]}]},{"name":"ImmuDocs National Doctoral Education Pilot Based on the Immune System","award":["Document ID 704155"],"award-info":[{"award-number":["Document ID 704155"]}]},{"name":"ImmuDocs National Doctoral Education Pilot Based on the Immune System","award":["OKM\/14\/523\/2024"],"award-info":[{"award-number":["OKM\/14\/523\/2024"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2025,5,4]]},"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multiple sclerosis (MS) progression independent of relapses is driven by brain innate immune cell activation. The aim of this study was to evaluate the association between chitinase-3-like protein 1 (CHI3L1), expressed in brain by astrocytes and microglia, measured from blood and smouldering inflammation measured using 18\u2009kDa translocator protein (TSPO) positron emission tomography (PET) in patients with MS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The study cohort included 55 patients with MS (25 progressive MS (PMS) and 30 relapsing remitting MS (RRMS)) and 17 healthy controls (HC). CHI3L1 was measured with commercial ELISA from plasma samples. A subcohort (44\u2009MS and 9 HC) underwent TSPO-PET to assess [\n                      <jats:sup>11<\/jats:sup>\n                      C]PK11195 distribution volume ratio (DVR) and MRI concurrent to blood sampling. These imaging outcomes were used in respective correlation and linear regression analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      CHI3L1 concentration in plasma was higher in PMS (23.5\u2009ng\/mL) compared with HC (16.8\u2009ng\/mL, p=0.0055) and RRMS (19.3\u2009ng\/mL, p=0.049). CHI3L1 associated with brain [\n                      <jats:sup>11<\/jats:sup>\n                      C]PK11195 DVR in all MS (standardised estimate 0.89, 95% CI 0.23 to 1.55, p=0.010) and in PMS (Spearman correlation \u03c1=0.58, 95% CI 0.058 to 0.86, p=0.032). Additionally, CHI3L1 was associated with smaller brain volume in both MS (\u22120.75, \u22121.38 to \u20130.11, p=0.023) and PMS (\u03c1=\u22120.56, \u20130.83 to \u20130.095, p=0.021). Furthermore, CHI3L1 was associated with Expanded Disability Status Scale (0.70, 0.12 to 1.28, p=0.019) and age (0.93, 0.37 to 1.48, p=0.002) among all patients with MS.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Association of CHI3L1 with glial activation and brain volume loss identifies plasma CHI3L1 as a promising biomarker for smouldering inflammation and MS progression-related pathology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2025-336063","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T05:48:35Z","timestamp":1747720115000},"page":"1053-1060","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Plasma CHI3L1 associates with brain volume loss and glial activation in multiple sclerosis"],"prefix":"10.1136","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5615-5438","authenticated-orcid":false,"given":"Venla","family":"Ahola","sequence":"first","affiliation":[{"name":"Clinical Neurosciences, University of Turku, Turku, Finland"},{"name":"Turku PET Centre, University of Turku, Turku University Hospital, and \u00c5bo Akademi University, Turku, Finland"},{"name":"InFLAMES Research Flagship, University of Turku, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3424-5976","authenticated-orcid":false,"given":"Maija","family":"Saraste","sequence":"additional","affiliation":[{"name":"Clinical Neurosciences, University of Turku, Turku, Finland"},{"name":"Turku PET Centre, University of Turku, Turku University Hospital, and \u00c5bo Akademi University, Turku, Finland"},{"name":"InFLAMES Research Flagship, University of Turku, Turku, Finland"},{"name":"Neurocenter, Turku University Hospital, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6695-5684","authenticated-orcid":false,"given":"Marjo","family":"Nylund","sequence":"additional","affiliation":[{"name":"Clinical Neurosciences, University of Turku, Turku, Finland"},{"name":"Turku PET Centre, University of Turku, Turku University Hospital, and \u00c5bo Akademi University, Turku, Finland"},{"name":"InFLAMES Research Flagship, University of Turku, Turku, Finland"},{"name":"Neurocenter, Turku University Hospital, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5597-2670","authenticated-orcid":false,"given":"Markus","family":"Matilainen","sequence":"additional","affiliation":[{"name":"Clinical Neurosciences, University of Turku, Turku, Finland"},{"name":"Turku PET Centre, University of Turku, Turku University Hospital, and \u00c5bo Akademi University, Turku, Finland"},{"name":"InFLAMES Research Flagship, University of Turku, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5689-052X","authenticated-orcid":false,"given":"Amelie","family":"Luoma","sequence":"additional","affiliation":[{"name":"Clinical Neurosciences, University of Turku, Turku, Finland"},{"name":"Turku PET Centre, University of Turku, Turku University Hospital, and \u00c5bo Akademi University, Turku, Finland"},{"name":"InFLAMES Research Flagship, University of Turku, Turku, Finland"},{"name":"Neurocenter, Turku University Hospital, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0711-6917","authenticated-orcid":false,"given":"Anna","family":"Vuorimaa","sequence":"additional","affiliation":[{"name":"Clinical Neurosciences, University of Turku, Turku, Finland"},{"name":"Turku PET Centre, University of Turku, Turku University Hospital, and \u00c5bo Akademi University, Turku, Finland"},{"name":"InFLAMES Research Flagship, University of Turku, Turku, Finland"},{"name":"Neurocenter, Turku University Hospital, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2589-2549","authenticated-orcid":false,"given":"Jussi","family":"Lehto","sequence":"additional","affiliation":[{"name":"Turku PET Centre, University of Turku, Turku University Hospital, and \u00c5bo Akademi University, Turku, Finland"},{"name":"InFLAMES Research Flagship, University of Turku, Turku, Finland"},{"name":"Neurocenter, Turku University Hospital, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1273-8630","authenticated-orcid":false,"given":"Sini","family":"Laaksonen","sequence":"additional","affiliation":[{"name":"Clinical Neurosciences, University of Turku, Turku, Finland"},{"name":"Turku PET Centre, University of Turku, Turku University Hospital, and \u00c5bo Akademi University, Turku, Finland"},{"name":"InFLAMES Research Flagship, University of Turku, Turku, Finland"},{"name":"Neurocenter, Turku University Hospital, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0362-0402","authenticated-orcid":false,"given":"Eeva-Christine","family":"Brockmann","sequence":"additional","affiliation":[{"name":"Department of Life Technologies, Division of Biotechnology, University of Turku, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6963-8892","authenticated-orcid":false,"given":"Jens","family":"Kuhle","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital and University of Basel, Basel, Switzerland"},{"name":"Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6172-801X","authenticated-orcid":false,"given":"David","family":"Leppert","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital and University of Basel, Basel, Switzerland"},{"name":"Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1144-6724","authenticated-orcid":false,"given":"Tero","family":"Soukka","sequence":"additional","affiliation":[{"name":"InFLAMES Research Flagship, University of Turku, Turku, Finland"},{"name":"Department of Life Technologies, Division of Biotechnology, University of Turku, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6336-1407","authenticated-orcid":false,"given":"Urpo","family":"Lamminm\u00e4ki","sequence":"additional","affiliation":[{"name":"InFLAMES Research Flagship, University of Turku, Turku, Finland"},{"name":"Department of Life Technologies, Division of Biotechnology, University of Turku, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9751-5881","authenticated-orcid":false,"given":"Laura","family":"Airas","sequence":"additional","affiliation":[{"name":"Clinical Neurosciences, University of Turku, Turku, Finland"},{"name":"Turku PET Centre, University of Turku, Turku University Hospital, and \u00c5bo Akademi University, Turku, Finland"},{"name":"InFLAMES Research Flagship, University of Turku, Turku, Finland"},{"name":"Neurocenter, Turku University Hospital, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"2026081401350742000_96.11.1053.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2022.06.023"},{"key":"2026081401350742000_96.11.1053.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00537-1"},{"key":"2026081401350742000_96.11.1053.3","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.131698"},{"key":"2026081401350742000_96.11.1053.4","doi-asserted-by":"publisher","DOI":"10.1007\/s40336-015-0147-6"},{"key":"2026081401350742000_96.11.1053.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2014.01.018"},{"key":"2026081401350742000_96.11.1053.6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/acn3.51969","article-title":"Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis","volume":"11","author":"Abdelhak","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"2026081401350742000_96.11.1053.7","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00009-6"},{"key":"2026081401350742000_96.11.1053.8","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-00303-7","article-title":"Chitinase-3 like-protein-1 function and its role in diseases","volume":"5","author":"Zhao","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"2026081401350742000_96.11.1053.9","doi-asserted-by":"crossref","unstructured":"Cubas-N\u00fa\u00f1ez L , Gil-Perot\u00edn S , Castillo-Villalba J , et al . Potential Role of CHI3L1+ Astrocytes in Progression in MS. Neurol Neuroimmunol Neuroinflamm 2021;8. doi:10.1212\/NXI.0000000000000972","DOI":"10.1212\/NXI.0000000000000972"},{"key":"2026081401350742000_96.11.1053.10","doi-asserted-by":"crossref","unstructured":"Schneider R , Bellenberg B , Gisevius B , et al . Chitinase 3\u2013like 1 and neurofilament light chain in CSF and CNS atrophy in MS. Neurol Neuroimmunol Neuroinflamm 2021;8. doi:10.1212\/NXI.0000000000000906","DOI":"10.1212\/NXI.0000000000000906"},{"key":"2026081401350742000_96.11.1053.11","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514561906"},{"key":"2026081401350742000_96.11.1053.12","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv017"},{"key":"2026081401350742000_96.11.1053.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-02022-w","article-title":"K284-6111 alleviates memory impairment and neuroinflammation in Tg2576 mice by inhibition of Chitinase-3-like 1 regulating ERK-dependent PTX3 pathway","volume":"17","author":"Ham","year":"2020","journal-title":"J Neuroinflammation"},{"key":"2026081401350742000_96.11.1053.14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-64093-2","article-title":"Chitinase 3-like 1 is neurotoxic in primary cultured neurons","volume":"10","author":"Matute-Blanch","year":"2020","journal-title":"Sci Rep"},{"key":"2026081401350742000_96.11.1053.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114226"},{"key":"2026081401350742000_96.11.1053.16","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001164","article-title":"Role of Chitinase 3-like 1 as a Biomarker in Multiple Sclerosis: A Systematic Review and Meta-analysis","volume":"9","author":"Floro","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2026081401350742000_96.11.1053.17","first-page":"3933","article-title":"Correlation of selected serum protein levels with the degree of disability and NEDA-3 status in multiple sclerosis phenotypes","volume":"26","author":"Lamancov\u00e1","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2026081401350742000_96.11.1053.18","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511433063"},{"key":"2026081401350742000_96.11.1053.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2"},{"key":"2026081401350742000_96.11.1053.20","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000691","article-title":"Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging","volume":"7","author":"Bezukladova","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2026081401350742000_96.11.1053.21","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae013"},{"key":"2026081401350742000_96.11.1053.22","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab301","article-title":"Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PET","volume":"4","author":"Nylund","year":"2022","journal-title":"Brain Commun"},{"key":"2026081401350742000_96.11.1053.23","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000443","article-title":"Microglial activation, white matter tract damage, and disability in MS","volume":"5","author":"Rissanen","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2026081401350742000_96.11.1053.24","first-page":"158","article-title":"Reference and target region modeling of [11C]-(R)-PK11195 brain studies","volume":"48","author":"Turkheimer","year":"2007","journal-title":"J Nucl Med"},{"key":"2026081401350742000_96.11.1053.25","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2012.59"},{"key":"2026081401350742000_96.11.1053.26","doi-asserted-by":"crossref","DOI":"10.1177\/17562864241306684","article-title":"Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance","volume":"17","author":"Dal-Bianco","year":"2024","journal-title":"Ther Adv Neurol Disord"},{"key":"2026081401350742000_96.11.1053.27","doi-asserted-by":"publisher","DOI":"10.1002\/ana.27034"},{"key":"2026081401350742000_96.11.1053.28","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00608","article-title":"A Score Based on NfL and Glial Markers May Differentiate Between Relapsing-Remitting and Progressive MS Course","volume":"11","author":"Huss","year":"2020","journal-title":"Front Neurol"},{"key":"2026081401350742000_96.11.1053.29","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1249-7","article-title":"Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis","volume":"15","author":"H\u00e5kansson","year":"2018","journal-title":"J Neuroinflammation"},{"key":"2026081401350742000_96.11.1053.30","doi-asserted-by":"publisher","DOI":"10.1177\/13524585211010082"},{"key":"2026081401350742000_96.11.1053.31","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000422","article-title":"Neurofilament light chain predicts disease activity in relapsing-remitting MS","volume":"5","author":"Varhaug","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2026081401350742000_96.11.1053.32","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-332251"},{"key":"2026081401350742000_96.11.1053.33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201504-0760OC"},{"key":"2026081401350742000_96.11.1053.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2012.03.034"},{"key":"2026081401350742000_96.11.1053.35","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-1144"},{"key":"2026081401350742000_96.11.1053.36","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.10.828"},{"key":"2026081401350742000_96.11.1053.37","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200045","article-title":"Effect of Estimated Blood Volume and Body Mass Index on GFAP and NfL Levels in the Serum and CSF of Patients With Multiple Sclerosis","volume":"10","author":"Yalachkov","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2026081401350742000_96.11.1053.38","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0994"},{"key":"2026081401350742000_96.11.1053.39","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-331051"},{"key":"2026081401350742000_96.11.1053.40","doi-asserted-by":"publisher","DOI":"10.1177\/1352458510392619"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2025-336063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:35:24Z","timestamp":1786696524000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2025-336063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,10,15]]},"published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1136\/jnnp-2025-336063"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2025-336063","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]}}}